APA (7th ed.) Citation

HE, C., AM, B., CE, L., MR, L., J, P., AE, P., . . . R, K. (2025). Advancing the Management of CH, MDS, and AML From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference. Clinical lymphoma, myeloma & leukemia, 25(8), 583. https://doi.org/10.1016/j.clml.2025.03.005

Chicago Style (17th ed.) Citation

HE, Carraway, et al. "Advancing the Management of CH, MDS, and AML From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference." Clinical Lymphoma, Myeloma & Leukemia 25, no. 8 (2025): 583. https://doi.org/10.1016/j.clml.2025.03.005.

MLA (9th ed.) Citation

HE, Carraway, et al. "Advancing the Management of CH, MDS, and AML From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference." Clinical Lymphoma, Myeloma & Leukemia, vol. 25, no. 8, 2025, p. 583, https://doi.org/10.1016/j.clml.2025.03.005.